Brain-derived neurotrophic factor expression ex vivo in obesity

Physiology and Behavior

Volumn 123, Issue , 2014, Pages 76-79

  Huang, Chun Jung ^a   Mari, David C ^a   Whitehurst, Michael ^a   Slusher, Aaron ^a   Wilson, Alan ^a   Shibata, Yoshimi ^b  

^a FLORIDA ATLANTIC UNIVERSITY   (United States)

^b FLORIDA ATLANTIC UNIVERSITY   (United States)

Author keywords

Brain derived neurotrophic factor; Interleukin 6; Lipopolysaccharide; Obesity; Tumor necrosis factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; BLOOD SAMPLING; CELL CULTURE; CELL SURVIVAL; CLINICAL ARTICLE; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; EX VIVO STUDY; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; MALE; NERVE CELL LESION; NERVE CELL PLASTICITY; OBESITY; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT;

BRAIN-DERIVED NEUROTROPHIC FACTOR; INTERLEUKIN-6; LIPOPOLYSACCHARIDE; OBESITY; TUMOR NECROSIS FACTOR-Α;

ADOLESCENT; ADULT; ANTHROPOMETRY; BRAIN-DERIVED NEUROTROPHIC FACTOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; MALE; OBESITY; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84886565804     PISSN: 00319384     EISSN: 1873507X     Source Type: Journal    
DOI: 10.1016/j.physbeh.2013.10.004     Document Type: Article

References (36)

1. Sellbom K.S., Gunstad J. Cognitive function and decline in obesity. J Alzheimers Dis 2012, 30(Suppl. 2):S89-S95.
2. Jones A., McMillan M.R., Jones R.W., Kowalik G.T., Steeden J.A., Deanfield J.E., et al. Adiposity is associated with blunted cardiovascular, neuroendocrine and cognitive responses to acute mental stress. PLoS One 2012, 7:e39143.
3. Smith E., Hay P., Campbell L., Trollor J.N. A review of the association between obesity and cognitive function across the lifespan: implications for novel approaches to prevention and treatment. Obes Rev 2011, 12:740-755.
4. Ashrafian H., Harling L., Darzi A., Athanasiou T. Neurodegenerative disease and obesity: what is the role of weight loss and bariatric interventions?. Metab Brain Dis 2013, 28:341-353.
5. Tyler W.J., Perrett S.P., Pozzo-Miller L.D. The role of neurotrophins in neurotransmitter release. Neuroscientist 2002, 8:524-531.
6. Binder D.K., Scharfman H.E. Brain-derived neurotrophic factor. Growth Factors 2004, 22:123-131.
7. El-Gharbawy A.H., Adler-Wailes D.C., Mirch M.C., Theim K.R., Ranzenhofer L., Tanofsky-Kraff M., et al. Serum brain-derived neurotrophic factor concentrations in lean and overweight children and adolescents. J Clin Endocrinol Metab 2006, 91:3548-3552.
8. Krabbe K.S., Nielsen A.R., Krogh-Madsen R., Plomgaard P., Rasmussen P., Erikstrup C., et al. Brain-derived neurotrophic factor (BDNF) and type 2 diabetes. Diabetologia 2007, 50:431-438.
9. Monteleone P., Tortorella A., Martiadis V., Serritella C., Fuschino A., Maj M. Opposite changes in the serum brain-derived neurotrophic factor in anorexia nervosa and obesity. Psychosom Med 2004, 66:744-748.
10. Nakagawa T., Tsuchida A., Itakura Y., Nonomura T., Ono M., Hirota F., et al. Brain-derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic mice. Diabetes 2000, 49:436-444.
11. Suwa M., Kishimoto H., Nofuji Y., Nakano H., Sasaki H., Radak Z., et al. Serum brain-derived neurotrophic factor level is increased and associated with obesity in newly diagnosed female patients with type 2 diabetes mellitus. Metabolism 2006, 55:852-857.
12. Roth C.L., Elfers C., Gebhardt U., Müller H.L., Reinehr T. Brain-derived neurotrophic factor and its relation to leptin in obese children before and after weight loss. Metabolism 2013, 62:226-234.
13. Kerschensteiner M., Gallmeier E., Behrens L., Leal V.V., Misgeld T., Klinkert W.E., et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation?. J Exp Med 1999, 189:865-870.
14. Lommatzsch M., Niewerth A., Klotz J., Schulte-Herbrüggen O., Zingler C., Schuff-Werner P., et al. Platelet and plasma BDNF in lower respiratory tract infections of the adult. Respir Med 2007, 101:1493-1499.
15. Stadelmann C., Kerschensteiner M., Misgeld T., Brück W., Hohlfeld R., Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?. Brain 2002, 125:75-85.
16. Munger K.L., Bentzen J., Laursen B., Stenager E., Koch-Henriksen N., Sørensen T.I., et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study. Mult Scler 2013, 19:1323-1329.
17. Lukens J.R., Dixit V.D., Kanneganti T.D. Inflammasome activation in obesity-related inflammatory diseases and autoimmunity. Discov Med 2011, 12:65-74.
18. Heneka M.T., O'Banion M.K., Terwel D., Kummer M.P. Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 2010, 117:919-947.
19. Morales I., Farias G., Maccioni R.B. Neuroimmunomodulation in the pathogenesis of Alzheimer's disease. Neuroimmunomodulation 2010, 17:202-204.
20. Yaffe K., Lindquist K., Penninx B.W., Simonsick E.M., Pahor M., Kritchevsky S., et al. Inflammatory markers and cognition in well-functioning African-American and white elders. Neurology 2003, 61:76-80.
21. Jung J.E., Kim G.S., Chan P.H. Neuroprotection by interleukin-6 is mediated by signal transducer and activator of transcription 3 and antioxidative signaling in ischemic stroke. Stroke 2011, 42:3574-3579.
22. Nakafuku M., Satoh T., Kaziro Y. Differentiation factors, including nerve growth factor, fibroblast growth factor, and interleukin-6, induce an accumulation of an active Ras.GTP complex in rat pheochromocytoma PC12 cells. J Biol Chem 1992, 267:19448-19454.
23. Yang P., Wen H., Ou S., Cui J., Fan D. IL-6 promotes regeneration and functional recovery after cortical spinal tract injury by reactivating intrinsic growth program of neurons and enhancing synapse formation. Exp Neurol 2012, 236:19-27.
24. Perígolo-Vicente R., Ritt K., Pereira M.R., Torres P.M., Paes-de-Carvalho R., Giestal-de-Araujo E. IL-6 treatment increases the survival of retinal ganglion cells in vitro: the role of adenosine A1 receptor. Biochem Biophys Res Commun 2013, 430:512-518.
25. Schulte-Herbrüggen O., Nassenstein C., Lommatzsch M., Quarcoo D., Renz H., Braun A. Tumor necrosis factor-alpha and interleukin-6 regulate secretion of brain-derived neurotrophic factor in human monocytes. J Neuroimmunol 2005, 160:204-209.
26. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-429.
27. Basu S., Haghiac M., Surace P., Challier J.C., Guerre-Millo M., Singh K., et al. Pregravid obesity associates with increased maternal endotoxemia and metabolic inflammation. Obesity (Silver Spring) 2011, 19:476-482.
28. Gonzalez-Quintela A., Alonso M., Campos J., Vizcaino L., Loidi L., Gude F. Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity. PLoS One 2013, 8:e54600.
29. Rios M., Fan G., Fekete C., Kelly J., Bates B., Kuehn R., et al. Conditional deletion of brain-derived neurotrophic factor in the postnatal brain leads to obesity and hyperactivity. Mol Endocrinol 2001, 15:1748-1757.
30. Han J.C., Muehlbauer M.J., Cui H.N., Newgard C.B., Haqq A.M. Lower brain-derived neurotrophic factor in patients with Prader-Willi syndrome compared to obese and lean control subjects. J Clin Endocrinol Metab 2010, 95:3532-3536.
31. Corripio R., Gónzalez-Clemente J.M., Jacobo P.S., Silvia N., Lluis G., Joan V., et al. Plasma brain-derived neurotrophic factor in prepubertal obese children: results from a 2-year lifestyle intervention programme. Clin Endocrinol (Oxf) 2012, 77:715-720.
32. Nikolac Perkovic M., Mustapic M., Pavlovic M., Uzun S., Kozumplik O., Barisic I., et al. Lack of association between brain-derived neurotrophic factor Val66Met polymorphism and body mass index change over time in healthy adults. Neurosci Lett 2013, 545:127-131.
33. Brietzke E., Stertz L., Fernandes B.S., Kauer-Sant'anna M., Mascarenhas M., Escosteguy Vargas A., et al. Comparison of cytokine levels in depressed, manic and euthymic patients with bipolar disorder. J Affect Disord 2009, 116:214-217.
34. Angelopoulos P., Agouridaki H., Vaiopoulos H., Siskou E., Doutsou K., Costa V., et al. Cytokines in Alzheimer's disease and vascular dementia. Int J Neurosci 2008, 118:1659-1672.
35. Vega J.A., García-Suárez O., Hannestad J., Pérez-Pérez M., Germanà A. Neurotrophins and the immune system. J Anat 2003, 203:1-19.
36. Fujimura H., Altar C.A., Chen R., Nakamura T., Nakahashi T., Kambayashi J., et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost 2002, 87:728-734.